Logotipo do repositório
 

Publicação:
Antimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteria

dc.contributor.authorde Pontes, Janaína Teixeira Costa [UNESP]
dc.contributor.authorBorges, Anna Beatriz Toledo [UNESP]
dc.contributor.authorRoque-Borda, Cesar Augusto [UNESP]
dc.contributor.authorPavan, Fernando Rogério [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversidad Católica de Santa María
dc.date.accessioned2022-05-01T15:46:21Z
dc.date.available2022-05-01T15:46:21Z
dc.date.issued2022-03-01
dc.description.abstractBacterial resistance is an emergency public health problem worldwide, compounded by the ability of bacteria to form biofilms, mainly in seriously ill hospitalized patients. The World Health Organization has published a list of priority bacteria that should be studied and, in turn, has encouraged the development of new drugs. Herein, we explain the importance of studying new molecules such as antimicrobial peptides (AMPs) with potential against multi-drug resistant (MDR) and extensively drug-resistant (XDR) bacteria and focus on the inhibition of biofilm formation. This review describes the main causes of antimicrobial resistance and biofilm formation, as well as the main and potential AMP applications against these bacteria. Our results suggest that the new biomacromolecules to be discovered and studied should focus on this group of dangerous and highly infectious bacteria. Alternative molecules such as AMPs could contribute to eradicating biofilm proliferation by MDR/XDR bacteria; this is a challenging undertaking with promising prospects.en
dc.description.affiliationTuberculosis Research Laboratory School of Pharmaceutical Science São Paulo State University (UNESP)
dc.description.affiliationVicerrectorado de Investigación Universidad Católica de Santa María
dc.description.affiliationUnespTuberculosis Research Laboratory School of Pharmaceutical Science São Paulo State University (UNESP)
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipIdCAPES: 001
dc.description.sponsorshipIdFAPESP: 2020/13497-4
dc.description.sponsorshipIdFAPESP: 2020/16573-3
dc.description.sponsorshipIdCNPq: 303603/2018-6
dc.description.sponsorshipIdCNPq: 404181/2019-8
dc.description.sponsorshipIdCNPq: 429139/2018-7
dc.identifierhttp://dx.doi.org/10.3390/pharmaceutics14030642
dc.identifier.citationPharmaceutics, v. 14, n. 3, 2022.
dc.identifier.doi10.3390/pharmaceutics14030642
dc.identifier.issn1999-4923
dc.identifier.scopus2-s2.0-85127137965
dc.identifier.urihttp://hdl.handle.net/11449/234319
dc.language.isoeng
dc.relation.ispartofPharmaceutics
dc.sourceScopus
dc.subjectantimicrobial peptides
dc.subjectantimicrobial resistance
dc.subjectbiofilm
dc.subjectdrug discovery
dc.subjectextensive drug resistance
dc.subjectMDR bacteria
dc.titleAntimicrobial Peptides as an Alternative for the Eradication of Bacterial Biofilms of Multi-Drug Resistant Bacteriaen
dc.typeResenhapt
dspace.entity.typePublication
relation.isDepartmentOfPublication5004bcab-94af-4939-b980-091ae9d0a19e
relation.isDepartmentOfPublication.latestForDiscovery5004bcab-94af-4939-b980-091ae9d0a19e
unesp.departmentCiências Biológicas - FCFpt

Arquivos